Preliminary scientific tests indicate conolidine may possibly inhibit distinct ion channels, decreasing neuronal excitability and limiting ache signals. This system is particularly appropriate in neuropathic suffering, where by abnormal signaling brings about persistent soreness. Also, conolidine seems to influence G protein-coupled receptor (GPCR) pathways integral to suffering perce... https://robertoq479soj7.59bloggers.com/profile